These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 270597)

  • 1. Acute myelogenous leukemia as a late complication of the multimodality therapy for Hodgkin's disease.
    Trump DL; Cowall DE
    Johns Hopkins Med J; 1977 Nov; 141(5):249-51. PubMed ID: 270597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
    Lipton JH; Gospodarowicz M; Reingold S
    Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
    Lira P; Grebe G
    Rev Med Chil; 1984 Oct; 112(10):1021-5. PubMed ID: 6085597
    [No Abstract]   [Full Text] [Related]  

  • 4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute myeloid leukemia after treatment of Hodgkin's disease].
    Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's disease terminating as acute leukaemia: case report and review of the literature.
    Wakem CJ; Bennett JM
    N Z Med J; 1972 Sep; 76(484):187-94. PubMed ID: 4508745
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute leukemia in patients treated for Hodgkin's disease].
    Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R
    Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542
    [No Abstract]   [Full Text] [Related]  

  • 8. [The current state of curability of Hodgkin's disease].
    Streuli RA; Ultmann JE
    Schweiz Med Wochenschr; 1981 Sep; 111(36):1301-3. PubMed ID: 7302531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of terminal leukemia in a patient with Hodgkin's disease].
    Quaglino D; Emilia G; Di Prisco AU; De Pasquale A; Zagni G
    Minerva Med; 1975 Feb; 66(15):689-98. PubMed ID: 1054112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lymphoblastic leukemia following Hodgkin's disease.
    Saleem A; Johnston RL
    Ann Clin Lab Sci; 1980; 10(2):100-4. PubMed ID: 6930197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute myeloid leukemia during Hodgkin's disease].
    Dziewulska-Bokiniec A; Jassem J
    Acta Haematol Pol; 1979; 10(2):137-40. PubMed ID: 289273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in the treatment of Hodgkin's disease].
    Jacquillat C
    Acquis Med Recent; 1977; ():89-98. PubMed ID: 910606
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
    Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hematologic tumors].
    Ogawa M
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1416-21. PubMed ID: 14584273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of Hodgkin's disease.
    Fairley GH
    Trans Med Soc Lond; 1972; 88():61-71. PubMed ID: 4665820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.